Facilitated By

San Antonio Medical Foundation

News

  • Moderna: Q2 Earnings Snapshot

    The biotechnology company posted revenue of $4.35 billion in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected ...

  • Salarius: Q2 Earnings Snapshot

    The biotech drug developer posted revenue of $571,400 in the period. Its adjusted revenue was $571,000. The company's shares closed at 80 cents.

  • Calithera: Q2 Earnings Snapshot

    SOUTH SAN FRANCISCO, Calif. (AP) _ Calithera Biosciences Inc. (CALA) on Thursday reported a loss of $14.3 million in its second quarter.

  • NGM Biopharmaceuticals: Q2 Earnings Snapshot

    The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share. The biotechnology company posted ...

  • Fate Therapeutics: Q2 Earnings Snapshot

    The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share. The clinical-stage biotech company ...